Sandoz Canada Losartan/Losartan-HCT…

Category: Drugs

Issue: Product Safety

Audience: General Public, Healthcare Professionals, Hospitals

Department: Health Canada

Hazard classification: Type I

Alert type: Drug Recall

Losartan 25 mg Tablet

Lot or serial number	Companies	Brand name	DIN, NPN, DIN-HIM	Dosage form	Strength
KG4858, KU3078, KS3076, KZ7522, KG4859, KS3077, KZ7520	Recalling Firm Sandoz Canada Inc 110 de Lauzon Boucherville J4B 1E6 Quebec CANADA Marketing Authorization Holder Sandoz Canada Inc 110 de Lauzon Boucherville J4B 1E6 Quebec CANADA	Losartan/HCT 100 mg / 25 mg Tablet	DIN 02313383	Tablet	Hydrochlorothiazide 25 mg, Losartan Potassium 100 mg
KF3705, KF3706, KR8908, KS7564, KX6497, LB3649, KR7041, KS5626, KS5627, KX6500	Recalling Firm Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA Marketing Authorization Holder Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA	Losartan/HCT 50 mg / 12.5 mg Tablet	DIN 02313375	Tablet	Hydrochlorothiazide 12.5 mg, Losartan Potassium 50 mg
KF3628, KS3893, KT2043, KY9842, LB1657, KF3714, KS3889, KS3890, KT2044, KY9846	Recalling Firm Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA Marketing Authorization Holder Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA	Losartan/HCT 100 mg / 12.5 mg Tablet	DIN 02362449	Tablet	Hydrochlorothiazide 12.5 mg, Losartan Potassium 100 mg
KF3629, KS1008, KS1009, KS8837, KT8356, KY8356, KY7473, KS1006, KY7472	Recalling Firm Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA Marketing Authorization Holder Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA	Losartan 50 mg Tablet	DIN 02313340	Tablet	Losartan Potassium 50 mg
KF3630, KR6172, KS7551, LA1962, LD1621, LJ2275, KR6171, LA0665	Recalling Firm Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA Marketing Authorization Holder Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA	Losartan 100 mg Tablet	DIN 02313359	Tablet	Losartan Potassium 25 mg
KF3703, KF3704, KR0055, KS3238, KV8085, KY3612	Recalling Firm Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA Marketing Authorization Holder Sandoz Canada Incorporated 110 Rue De Lauzon Boucherville J4B 1E6 Quebec CANADA		DIN 02313332	Tablet	Losartan Potassium 25 mg

Losartan 25 mg Tablet
Losartan 50 mg Tablet
Losartan 100 mg Tablet
Losartan/HCT 50 mg / 12.5 mg Tablet
Losartan/HCT 100 mg / 12.5 mg Tablet
Losartan/HCT 100 mg / 25 mg Tablet

Presence of impurity 5-(4'-(azidomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.

Retailers

http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715a-eng.php

Allergies Food poisoning Children & Infants Medicine & Drugs Medical devices Blood pressure drugs Vehicles Hyundai Kia Airbag recalls

Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.

You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.

Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.

Recall Monitor is not endorsed by, or is an official product of the Government of Canada.

Made with in Vancouver, BC

Sandoz Canada Losartan/Losartan-HCT Product Recall (2021-09-13)
Health Products
Sep 13th, 2021 @ 12:00 AM

Basic Details

Summary

Product

Products

Introduction

Reason

Depth of distribution

For more information

About

Why subscribe?

Social

Recall Monitor

Sandoz Canada Losartan/Losartan-HCT Product Recall (2021-09-13)Health ProductsSep 13th, 2021 @ 12:00 AM